UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

Vascular medicine (London, England), 2020-04, Vol.25 (2), p.103-105

Hiatt, William R

2020

Volltextzugriff (PDF)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Vascular medicine (London, England), 2015-10, Vol.20 (5), p.465-478

2015

Volltextzugriff (PDF)

The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program

Vascular medicine (London, England), 2008-02, Vol.13 (1), p.15-24

2008

Volltextzugriff (PDF)

Lost in translation: Why ‘lost to follow-up’ matters

Vascular medicine (London, England), 2019-08, Vol.24 (4), p.339-340

2019

Volltextzugriff (PDF)

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial

Vascular medicine (London, England), 2018-12, Vol.23 (6), p.523-530

2018

Volltextzugriff (PDF)

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial

Vascular medicine (London, England), 2022-02, Vol.27 (1), p.21-29

2022

Volltextzugriff (PDF)

A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication

Vascular medicine (London, England), 2010-06, Vol.15 (3), p.181-188

2010

Volltextzugriff (PDF)

A systematic review and meta-analysis of propionyl-l-carnitine effects on exercise performance in patients with claudication

Vascular medicine (London, England), 2013-02, Vol.18 (1), p.3-12

2013

Volltextzugriff (PDF)

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

Vascular medicine (London, England), 2014-12, Vol.19 (6), p.473-482

2014

Volltextzugriff (PDF)

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial

Vascular medicine (London, England), 2019-10, Vol.24 (5), p.422-430

2019

Volltextzugriff (PDF)

Prognostic value of an increase in post-exercise ankle-brachial index

Vascular medicine (London, England), 2017-06, Vol.22 (3), p.204-209

2017

Volltextzugriff (PDF)

Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial

Vascular medicine (London, England), 2021-12, Vol.26 (6), p.608-612

2021

Volltextzugriff (PDF)

Community-based walking exercise for peripheral artery disease: An exploratory pilot study

Vascular medicine (London, England), 2015-08, Vol.20 (4), p.339-347

2015

Volltextzugriff (PDF)

Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training

Vascular medicine (London, England), 2012-04, Vol.17 (2), p.94-100

2012

Volltextzugriff (PDF)

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: Safety, walking distance and endothelial function

Vascular medicine (London, England), 2014-02, Vol.19 (1), p.9-17

2014

Volltextzugriff (PDF)

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution

Vascular medicine (London, England), 2018-12, Vol.23 (6), p.513-522

2018

Volltextzugriff (PDF)

Utility and barriers to performance of the ankle brachial index in primary care practice

Vascular medicine (London, England), 2004-11, Vol.9 (4), p.253-260

2004

Volltextzugriff (PDF)

Progression of asymptomatic peripheral artery disease over 1 year

Vascular medicine (London, England), 2012-02, Vol.17 (1), p.10-16

2012

Volltextzugriff (PDF)

l-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: A multicenter, randomized, double-blind, placebo-controlled trial

Vascular medicine (London, England), 2012-06, Vol.17 (3), p.145-154

2012

Volltextzugriff (PDF)

A validated biomarker panel to identify peripheral artery disease

Vascular medicine (London, England), 2012-12, Vol.17 (6), p.386-393

2012

Volltextzugriff (PDF)

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease

Vascular medicine (London, England), 2014-08, Vol.19 (4), p.297-306

2014

Volltextzugriff (PDF)

Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies

Vascular medicine (London, England), 2006-08, Vol.11 (3), p.141-145

2006

Volltextzugriff (PDF)

Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease

Vascular medicine (London, England), 2000-02, Vol.5 (1), p.55-59

2000

Volltextzugriff (PDF)

Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion

Vascular medicine (London, England), 2004-11, Vol.9 (4), p.293-301

2004

Volltextzugriff (PDF)

The Society for Vascular Medicine: The first quarter century

Vascular medicine (London, England), 2015-02, Vol.20 (1), p.60-68

2015

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieVascular Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Cardiovascular System & Cardiology
(41)
Life Sciences & Biomedicine
(41)
Peripheral Vascular Disease
(41)
Science & Technology
(41)
Humans
(40)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Cardiology. Vascular System
(23)
Blood And Lymphatic Vessels
(22)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(22)
Aged
(20)
Male
(20)
Middle Aged
(19)
Female
(18)
Peripheral Artery Disease
(18)
Intermittent Claudication - Drug Therapy
(16)
Peripheral Arterial Disease
(15)
Claudication
(14)
Pharmacology. Drug Treatments
(14)
Risk Factors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Electronic Journals Library
(57)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(57)
SAGE Journals
(57)
MEDLINE
(40)

Zeitschrift / Serie

Vascular Medicine Review
(1)

Menü

Weitere Dienste

Einstellungen

From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC)

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program

Lost in translation: Why ‘lost to follow-up’ matters

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial

A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication

A systematic review and meta-analysis of propionyl-l-carnitine effects on exercise performance in patients with claudication

Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial

Prognostic value of an increase in post-exercise ankle-brachial index

Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial

Community-based walking exercise for peripheral artery disease: An exploratory pilot study

Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training

Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: Safety, walking distance and endothelial function

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution

Utility and barriers to performance of the ankle brachial index in primary care practice

Progression of asymptomatic peripheral artery disease over 1 year

l-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: A multicenter, randomized, double-blind, placebo-controlled trial

A validated biomarker panel to identify peripheral artery disease

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease

Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies

Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease

Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point-counterpoint discussion

The Society for Vascular Medicine: The first quarter century

Aktive Filter

Suchergebnisse filtern